The use of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) as a pathway-specific biomarker with AZD8186, a PI3Kβ/δ inhibitor
Crossref DOI link: https://doi.org/10.1186/s13550-016-0220-9
Published Online: 2016-08-11
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maynard, Juliana
Emmas, Sally-Ann
Blé, Francois-Xavier
Barjat, Hervé
Lawrie, Emily
Hancox, Urs
Oakes, Deborah
Polanska, Urszula M.
Barry, Simon T.
License valid from 2016-08-11